Pregnancy differentially impacts performance of latent tuberculosis diagnostics in a high-burden setting

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Mathad, Jyoti S ^a   Bhosale, Ramesh ^b   Sangar, Vikrant ^c   Mave, Vidya ^c,d   Gupte, Nikhil ^c,d   Kanade, Savita ^c   Nangude, Ashwini ^c   Chopade, Kavita ^c   Suryavanshi, Nishi ^c   Deshpande, Prasad ^c   Kulkarni, Vandana ^c   Glesby, Marshall J ^a   Fitzgerald, Daniel ^a   Bharadwaj, Renu ^b   Sambarey, Pradeep ^b   Gupta, Amita ^c,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Sassoon General Hospital   (India)

^c Byramjee Jeejeebhoy Medical College   (India)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELIVERY; DEVELOPING COUNTRY; FEMALE; HUMAN; INDIA; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PROSPECTIVE STUDY; PUERPERIUM; TUBERCULIN TEST; TUBERCULOSIS CONTROL; ADOLESCENT; ADULT; COMPARATIVE STUDY; DIAGNOSTIC ERROR; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; MASS SCREENING; PREGNANCY COMPLICATIONS, INFECTIOUS; PROCEDURES; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DELIVERY, OBSTETRIC; DIAGNOSTIC ERRORS; FEMALE; HUMANS; INDIA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MASS SCREENING; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; TUBERCULIN TEST;

EID: 84899092782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092308     Document Type: Article

References (41)

1. World Health Organization (2012) Global tuberculosis report 2012 (in IRIS). Geneva: World Health Organization. viii, 272 p. p.
2. Zenner D, Kruijshaar ME, Andrews N, Abubakar I (2012) Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med 185: 779-784.
3. Good JT Jr, Iseman MD, Davidson PT, Lakshminarayan S, Sahn SA (1981) Tuberculosis in association with pregnancy. Am J Obstet Gynecol 140: 492-498. (Pubitemid 11093127)
4. Grange J, Adhikari M, Ahmed Y, Mwaba P, Dheda K, et al. (2010) Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in Sub-Saharan Africa. Int J Gynaecol Obstet 108: 181-183.
5. Mathad JS, Gupta A (2012) Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis 55: 1532-1549.
6. Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr, et al. (2009) Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 106: 13980-13985.
7. Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17: 968-975. (Pubitemid 23358739)
8. Covelli HD, Wilson RT (1978) Immunologic and medical considerations in tuberculin-sensitized pregnant patients. Am J Obstet Gynecol 132: 256-259. (Pubitemid 8399406)
9. Jackson TD, Murtha AP (2001) Anergy during pregnancy. Am J Obstet Gynecol 184: 1090-1092. (Pubitemid 32434252)
10. Worjoloh A, Kato-Maeda M, Osmond D, Freyre R, Aziz N, et al. (2011) Interferon gamma release assay compared with the tuberculin skin test for latent tuberculosis detection in pregnancy. Obstet Gynecol 118: 1363-1370.
11. Chehab BM KK, El Fakih RO, Zackula RE, Minns GO (2010) Use of the QuantiFERON-TB Gold Assay in Pregnant Patients. Kansas Journal of Medicine 3: 24-30.
12. Lighter-Fisher J, Surette AM (2012) Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy. Obstet Gynecol 119: 1088-1095.
13. Coates J SA, Bilinsky P (August 2007) Household Food Insecurity Access Scale (HFIAS) for Measurement of Household Food Access (v.3). Washington, DC: Food and Nutrition Technical Assistance Project.
14. QuantiFERON-TB Gold (In-Tube Method) [package insert]. Cellestis, Inc Valencia, CA: January 2009.
15. American Thoracic Society (2000) Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 161: 1376-1395.
16. Revised National Tuberculosis Control Programme (2006) India TB RNTCP Status Report. New Delhi, India: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare.
17. Munoz-Suano A, Hamilton AB, Betz AG (2011) Gimme shelter: the immune system during pregnancy. Immunol Rev 241: 20-38.
18. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184.
19. Sarrazin H, Wilkinson KA, Andersson J, Rangaka MX, Radler L, et al. (2009) Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons. J Infect Dis 199: 702-710.
20. Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, et al. (2011) Predictors of discordant tuberculin skin test and QuantiFERON-TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis 15: 1056-1061.
21. Machado A Jr, Emodi K, Takenami I, Finkmoore BC, Barbosa T, et al. (2009) Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. Int J Tuberc Lung Dis 13: 446-453.
22. Kim EY, Lim JE, Jung JY, Son JY, Lee KJ, et al. (2009) Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 9: 207.
23. Kim JH, Cho SK, Han M, Choi CB, Kim TH, et al. (2013) Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in Korean patients with rheumatic diseases. Semin Arthritis Rheum 42: 424-432.
24. Wilkinson KA, Wilkinson RJ, Pathan A, Ewer K, Prakash M, et al. (2005) Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 40: 184-187. (Pubitemid 40053478)
25. Kruse A, Martens N, Fernekorn U, Hallmann R, Butcher EC (2002) Alterations in the expression of homing-associated molecules at the maternal/fetal interface during the course of pregnancy. Biol Reprod 66: 333-345. (Pubitemid 34101829)
26. Singh N, Perfect JR (2007) Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 45: 1192-1199. (Pubitemid 47580319)
27. Jonnalagadda SR, Brown E, Lohman-Payne B, Wamalwa D, Farquhar C, et al. (2012) Consistency of Mycobacterium tuberculosis-specific interferon-gamma responses in HIV-1-infected women during pregnancy and postpartum. Infect Dis Obstet Gynecol 2012: 950650.
28. Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159: 15-21.
29. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M (2009) Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 4: e8517.
30. Ritz N, Yau C, Connell TG, Tebruegge M, Leslie D, et al. (2011) Absence of interferon-gamma release assay conversion following tuberculin skin testing. Int J Tuberc Lung Dis 15: 767-769.
31. Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, et al. (2011) Influence of previous tuberculin skin test on serial IFN-gamma release assays. Tuberculosis (Edinb) 91: 322-326.
32. Jonnalagadda S, Lohman Payne B, Brown E, Wamalwa D, Maleche Obimbo E, et al. (2010) Latent tuberculosis detection by interferon gamma release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis 202: 1826-1835.
33. Schulte JM, Bryan P, Dodds S, Potter M, Onorato IM, et al. (2002) Tuberculosis skin testing among HIV-infected pregnant women in Miami, 1995 to 1996. J Perinatol 22: 159-162. (Pubitemid 34213445)
34. Ojanuga DN, Gilbert C (1992) Women's access to health care in developing countries. Soc Sci Med 35: 613-617. (Pubitemid 23364852)
35. (2007) International Institute for Population Sciences (IIPS) and Macro International. National Family Health Survey (NFHS-3) 2005-06: Mumbai, India: IIPS.
36. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM (2000) Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev: CD001363.
37. World Health Organization., UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. (2011) Use of interferon-y (inteferon-gama) release assays (IGRAs) in tuberculosis control in low- and middle-income settngs: expert group meeting report 20-21July 2010. Geneva: World Health Organization. 177 p. p.
38. (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 49: 1-51.
39. Organization WH (2011) Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO.
40. Boggess KA, Myers ER, Hamilton CD (2000) Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. Obstet Gynecol 96: 757-762.
41. American Academy of Pediatrics Committee on D (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108: 776-789.